The stock of Teladoc Health Inc (NYSE: TDOC) has decreased by -1.72 when compared to last closing price of 9.87.Despite this, the company has seen a gain of 1.89% in its stock price over the last five trading days. globenewswire.com reported 2025-01-13 that PURCHASE, NY, Jan. 13, 2025 (GLOBE NEWSWIRE) — Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced a new collaboration with Amazon to expand access to Teladoc’s industry-leading chronic condition programs. Customers of Amazon that are eligible for Teladoc Health’s diabetes, hypertension, pre-diabetes and weight management programs can now seamlessly discover and enroll in these benefits directly through Amazon’s Health Benefits Connector, previously known as Health Condition Programs.
Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?
The stock has a 36-month beta value of 1.02. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 3 as “overweight,” 19 as “hold,” and 0 as “sell.”
The public float for TDOC is 168.52M, and at present, short sellers hold a 13.96% of that float. On January 14, 2025, the average trading volume of TDOC was 5.29M shares.
TDOC’s Market Performance
The stock of Teladoc Health Inc (TDOC) has seen a 1.89% increase in the past week, with a -8.49% drop in the past month, and a 2.21% gain in the past quarter. The volatility ratio for the week is 5.67%, and the volatility levels for the past 30 days are at 5.93% for TDOC. The simple moving average for the past 20 days is 0.36% for TDOC’s stock, with a -3.71% simple moving average for the past 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Goldman repeating the rating for TDOC by listing it as a “Buy.” The predicted price for TDOC in the upcoming period, according to Goldman is $14 based on the research report published on November 15, 2024 of the previous year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $10, previously predicting the price at $8. The rating they have provided for TDOC stocks is “Hold” according to the report published on September 17th, 2024.
Cantor Fitzgerald gave a rating of “Overweight” to TDOC, setting the target price at $22 in the report published on February 29th of the previous year.
TDOC Trading at -2.17% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.48% of loss for the given period.
Volatility was left at 5.93%, however, over the last 30 days, the volatility rate increased by 5.67%, as shares sank -8.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.74% upper at present.
During the last 5 trading sessions, TDOC rose by +1.89%, which changed the moving average for the period of 200-days by -35.55% in comparison to the 20-day moving average, which settled at $9.67. In addition, Teladoc Health Inc saw 6.71% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Nanis Nikolaos P., who proposed sale 502 shares at the price of $9.33 back on Jan 03 ’25. After this action, Nanis Nikolaos P. now owns shares of Teladoc Health Inc, valued at $4,681 using the latest closing price.
Waters Michael Willem, the Officer of Teladoc Health Inc, proposed sale 4,652 shares at $10.28 during a trade that took place back on Dec 16 ’24, which means that Waters Michael Willem is holding shares at $47,823 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.1 for the present operating margin
- 0.63 for the gross margin
The net margin for Teladoc Health Inc stands at -0.38. The total capital return value is set at -0.1. Equity return is now at value -51.65, with -24.99 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 1.02. The interest coverage ratio of the stock is -8.21.
Currently, EBITDA for the company is 154.0 million with net debt to EBITDA at -0.62. When we switch over and look at the enterprise to sales, we see a ratio of 0.78. The receivables turnover for the company is 11.58for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.69.
Conclusion
To sum up, Teladoc Health Inc (TDOC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
